Micromet AG
Records under this name other than patents Micromet AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,279,017 | Preparation of scFv antibody fragments Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,102,736 | Multispecific deimmunized CD3-binders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,901,278 | Pharmaceutical antibody compositions with resistance to soluble CEA Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,101,722 | Less immunogenic binding molecules Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,964,707 | Anti-IL2 antibodies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,154,617 | Means and Methods for the Treament of B Cell Non-Hodgkin Lymphoma and B Cell Leukemia Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,007,796 | Means and Methods for the Treatment of Tumorous Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 8,017,748 | Antibody neutralizers of human granulocyte macrophage colony stimulating factor Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,236,308 | Composition Comprising Cross-Species-Sepecific Antibodies and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,784,821 | Human-anti-human cd3 binding molecules Formerly held In force · From the USPTO record | In force | From the USPTO record |